Research location
Brighton
United Kingdom
Advertisement
Research activity in Brighton
United KingdomCureCurrent currently publishes aggregate city-level research activity for this location: 183 trials and 183 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Brighton
183 linked trials · page 1 of 4A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEFNCT07761117 · 2026-08-24 · 1 site observation
RECRUITING
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast CancerNCT07173751 · 2025-10-30 · 1 site observation
RECRUITING
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)NCT06883305 · 2025-03-18 · 1 site observation
RECRUITING
Supported Rescue Packs Post-discharge in Chronic Obstructive Pulmonary DiseaseNCT06347536 · 2025-01-30 · 1 site observation
RECRUITING
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung CancerNCT06712316 · 2025-01-07 · 1 site observation
RECRUITING
REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve FailureNCT06557798 · 2024-12-12 · 1 site observation
RECRUITING
Reduction of Mitral Regurgitation With the SATURN Trans-Septal Transcatheter Mitral Valve Replacement (TMVR) System in Patients With Severe Symptomatic Mitral RegurgitationNCT06414265 · 2024-04-04 · 1 site observation
RECRUITING
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine TherapyNCT05774951 · 2023-03-31 · 1 site observation
RECRUITING
A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)NCT05085028 · 2022-06-23 · 1 site observation
RECRUITING
A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast CancerNCT04985266 · 2022-03-30 · 1 site observation
RECRUITING
A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).NCT04319367 · 2021-05-17 · 1 site observation
RECRUITING
Axillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant ChemotherapyNCT04109079 · 2021-02-26 · 1 site observation
RECRUITING
The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis StudyNCT04204915 · 2020-03-10 · 1 site observation
RECRUITING
Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised TrialNCT04302870 · 2020-02-27 · 1 site observation
RECRUITING
Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.NCT00825929 · 2009-02-01 · 1 site observation
RECRUITING
A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or ObesityNCT07861100 · 2026-10-26 · 1 site observation
NOT_YET_RECRUITING
Study of Lenacapavir Taken Twice a Year for HIV Pre-Exposure Prophylaxis (PrEP)NCT06513312 · 2024-10-07 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant TherapyNCT05550532 · 2022-12-06 · 1 site observation
COMPLETED
Service User and Staff Views on Digital Remote Monitoring for PsychosisNCT05670197 · 2022-11-01 · 1 site observation
COMPLETED
The MISTRAL Study: Gut Microbiome Correlates of Serious AIDS and Non-AIDS EventsNCT05421286 · 2022-09-28 · 1 site observation
ACTIVE_NOT_RECRUITING
SCOOT: Sample Collection for DARTNCT05368298 · 2022-08-11 · 1 site observation
ACTIVE_NOT_RECRUITING
Implementing Long-Acting Novel AntiretroviralsNCT05294159 · 2022-07-18 · 1 site observation
COMPLETED
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLCNCT05211895 · 2022-02-18 · 1 site observation
ACTIVE_NOT_RECRUITING
Patients' Experiences and Perceptions of 3TC/DTG Dual Therapy (the PEDAL Study)NCT04901728 · 2021-07-01 · 1 site observation
UNKNOWN
Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular DiseaseNCT04915755 · 2021-06-28 · 1 site observation
ACTIVE_NOT_RECRUITING
Parent Intervention to Prevent Disordered Eating in Children With Type 1 DiabetesNCT04741568 · 2021-06-07 · 1 site observation
COMPLETED
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative TherapyNCT04873362 · 2021-05-04 · 1 site observation
ACTIVE_NOT_RECRUITING
PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -VNCT04870333 · 2021-02-19 · 1 site observation
COMPLETED
PreOperative Endocrine Therapy for Individualised Care With AbemaciclibNCT04584853 · 2020-12-23 · 1 site observation
ACTIVE_NOT_RECRUITING
Dapagliflozin Effects on Cardiometabolic Outcomes in Patients With an Acute Heart Attack.NCT04564742 · 2020-12-22 · 1 site observation
COMPLETED
Metastatic Prostate Cancer Men's Attitudes Towards Treatment of the Local Tumour and Metastasis Evaluative ResearchNCT04590976 · 2020-12-03 · 1 site observation
COMPLETED
A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)NCT04546009 · 2020-10-09 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy of BIC/F/TAF Versus Standard of Care in the Treatment of New HIV Infection Diagnoses in the Context of 'Test and Treat'NCT04653194 · 2020-09-30 · 1 site observation
COMPLETED
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-MutatedProstatic Neoplasms (mCSPC)NCT04497844 · 2020-09-23 · 1 site observation
ACTIVE_NOT_RECRUITING
Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents Versus Everolimus-Eluting Stents in Coronary Artery Disease Patients With Diabetes Mellitus GlobalNCT04236609 · 2020-06-15 · 1 site observation
UNKNOWN
A Study to Measure the Expression of the HER2-HER3 Dimer in Tumour and Blood (Exosomes) Samples From Patients With HER2 Positive Breast Cancer Receiving HER2 Targeted TherapiesNCT04288141 · 2019-12-20 · 1 site observation
UNKNOWN
Regimen Switch to Dolutegravir/Lamivudine Fixed Dose Combination From Current Antiretroviral Regimen in HIV-1 Infected and Virologically Suppressed Adults (SALSA)NCT04021290 · 2019-11-11 · 1 site observation
COMPLETED
SyncAV Post-Market TrialNCT04100148 · 2019-10-03 · 1 site observation
ACTIVE_NOT_RECRUITING
Paediatric Peri-operative Anxiety: Does the Little Journey App Help?NCT03797716 · 2019-09-09 · 1 site observation
COMPLETED
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in United Kingdom, as Part of Local Clinical Practice (SURE UK)NCT03876015 · 2019-05-01 · 1 site observation
COMPLETED
UK Ibrance Patient Program (IPP) StudyNCT03921866 · 2019-03-01 · 1 site observation
COMPLETED
Short or Long Antibiotic Regimes in OrthopaedicsNCT03806166 · 2019-02-21 · 1 site observation
COMPLETED
Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant CandidatesNCT03674307 · 2018-12-01 · 1 site observation
ACTIVE_NOT_RECRUITING
A Phase II Study Comparing The Efficacy Of Venetoclax + Fulvestrant Vs. Fulvestrant In Women With Estrogen Receptor-Positive, Her2-Negative Locally Advanced Or Metastatic Breast Cancer Who Experienced Disease Recurrence Or Progression During Or After CDK4/6 Inhibitor TherapyNCT03584009 · 2018-09-06 · 1 site observation
TERMINATED
A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast CancerNCT03493854 · 2018-06-14 · 1 site observation
COMPLETED
Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775])NCT03517449 · 2018-06-11 · 1 site observation
COMPLETED
Multiple Sclerosis-Simvastatin Trial 2NCT03387670 · 2018-03-28 · 1 site observation
COMPLETED
Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)NCT03446573 · 2018-01-18 · 1 site observation
COMPLETED
Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS)NCT03222973 · 2017-11-15 · 1 site observation
TERMINATED
Strategic Management to Optimize Response To Cardiac Resynchronization TherapyNCT03089281 · 2017-08-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.